Exelixis, Inc. logo

Exelixis, Inc.

NASDAQ:EXEL

Overview | Financials
Company Name Exelixis, Inc.
Symbol EXEL
Currency USD
Price 22.6
Market Cap 6,583,221,800
Dividend Yield 0%
52-week-range 18.64 - 24.34
Industry Biotechnology
Sector Healthcare
CEO Dr. Michael M. Morrissey Ph.D.
Website https://www.exelixis.com

An error occurred while fetching data.

About Exelixis, Inc.

Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment

Related Stocks

Sotera Health Company logo

Sotera Health Company

SHC

13.09 USD

10x Genomics, Inc. logo

10x Genomics, Inc.

TXG

16.7 USD

ShockWave Medical, Inc. logo

ShockWave Medical, Inc.

SWAV

334.75 USD

R1 RCM Inc. logo

R1 RCM Inc.

RCM

13.29 USD

Sarepta Therapeutics, Inc. logo

Sarepta Therapeutics, Inc.

SRPT

145.61 USD

Nutex Health, Inc. logo

Nutex Health, Inc.

NUTX

6.815 USD

Intra-Cellular Therapies, Inc. logo

Intra-Cellular Therapies, Inc.

ITCI

74.86 USD

Azenta, Inc. logo

Azenta, Inc.

AZTA

53.44 USD

Financials

Numbers are in millions USD

Numbers are in millions USD